Researchers have identified two molecular signals that drive the benefits of keloid radiotherapy, pointing toward treatments that do not require radiation access.
Keloids — dense, raised scars that grow beyond a wound's original boundary — affect people with darker skin tones at significantly higher rates, including many people with albinism who face heightened scarring risk from sun-related skin injuries and surgical procedures. How the most reliable treatment for keloids actually works at a molecular level has remained, until recently, poorly understood.
A study published in the Journal of Investigative Dermatology has moved that understanding forward. Researchers collected keloid tissue samples directly from patients, then cultured primary human keloid fibroblasts alongside normal skin fibroblasts in the laboratory. Using two broad analytical methods — non-targeted metabolomics and RNA sequencing — they mapped the biological changes that X-ray irradiation triggers inside keloid tissue.
What the researchers found
The study identified two key mediators of the treatment's effect: a lipid molecule called phytosphingosine (PHS) and a protein known as KIF20A. Together, the researchers reported, these two signals govern fibrosis activity and cell death in keloid tissue during radiotherapy.
Critically, the study found that X-ray irradiation suppresses keloid growth by pushing fibroblast cells into a state called G2/M arrest — a point in the cell cycle where division halts. The PHS–KIF20A axis, as the researchers described it, appears to be the mechanism that triggers this arrest. When that axis is activated, fibroblast proliferation slows, and the runaway scar growth characteristic of keloids is interrupted.
The significance of isolating this pathway lies in what it could make possible. Radiotherapy for keloids is clinically effective, the study noted, but access to it remains limited — equipment is expensive, specialist centres are few, and radiation carries its own risks with repeated exposure. If the biological pathway that explains radiotherapy's benefit can be replicated through other means, the researchers suggested, patients may one day have access to antifibrotic treatments that do not depend on radiation at all.
Why this matters for the community
For people with albinism, skin management is a sustained and careful practice across a lifetime. Sun exposure — unavoidable for most, and managed rather than eliminated — raises the likelihood of skin injuries that can result in scarring. Surgical procedures for skin cancer removal, more common in this community than in the general population, carry their own scarring risks. Treatments for conditions like keloids that are effective, accessible, and non-radiation-dependent would have direct practical value.
This study does not yet offer a clinical treatment. The research was conducted in laboratory conditions, using cell cultures derived from patient samples. The pathway it describes — PHS acting on KIF20A to halt cell division — now exists as a documented mechanism, available for the next stage of investigation.
The findings were published in the Journal of Investigative Dermatology. Clinical application, if it follows, would require further trials.
Keywords
Core topics and entities mentioned in this summary.